Abbrea Capital LLC boosted its holdings in shares of Danaher Co. (NYSE:DHR) by 4.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,778 shares of the conglomerate’s stock after purchasing an additional 120 shares during the quarter. Abbrea Capital LLC’s holdings in Danaher were worth $287,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in DHR. Ruggie Capital Group bought a new position in shares of Danaher in the fourth quarter worth about $40,000. We Are One Seven LLC bought a new position in shares of Danaher in the fourth quarter worth about $44,000. Legacy Financial Advisors Inc. grew its holdings in shares of Danaher by 59.4% in the fourth quarter. Legacy Financial Advisors Inc. now owns 690 shares of the conglomerate’s stock worth $71,000 after purchasing an additional 257 shares during the last quarter. NuWave Investment Management LLC grew its holdings in shares of Danaher by 5,600.0% in the fourth quarter. NuWave Investment Management LLC now owns 798 shares of the conglomerate’s stock worth $82,000 after purchasing an additional 784 shares during the last quarter. Finally, Parkside Financial Bank & Trust grew its holdings in shares of Danaher by 76.7% in the fourth quarter. Parkside Financial Bank & Trust now owns 1,016 shares of the conglomerate’s stock worth $105,000 after purchasing an additional 441 shares during the last quarter. 77.79% of the stock is currently owned by institutional investors.

Shares of Danaher stock opened at $111.22 on Thursday. The company has a current ratio of 1.47, a quick ratio of 1.07 and a debt-to-equity ratio of 0.34. Danaher Co. has a 1 year low of $94.12 and a 1 year high of $111.79. The stock has a market cap of $76.88 billion, a price-to-earnings ratio of 24.61, a price-to-earnings-growth ratio of 2.01 and a beta of 0.99.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, January 29th. The conglomerate reported $1.28 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.27 by $0.01. Danaher had a net margin of 13.33% and a return on equity of 11.64%. The company had revenue of $5.40 billion for the quarter, compared to analysts’ expectations of $5.33 billion. During the same period in the prior year, the business earned $1.19 EPS. The firm’s quarterly revenue was up 6.2% on a year-over-year basis. As a group, equities research analysts forecast that Danaher Co. will post 4.78 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Friday, January 25th. Shareholders of record on Friday, December 28th were issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 0.58%. The ex-dividend date was Thursday, December 27th. Danaher’s payout ratio is 14.16%.

DHR has been the topic of a number of research analyst reports. Royal Bank of Canada restated a “hold” rating and issued a $102.00 price target on shares of Danaher in a report on Wednesday, December 19th. Needham & Company LLC initiated coverage on shares of Danaher in a report on Wednesday, January 2nd. They issued a “buy” rating and a $114.00 price target on the stock. Cowen restated a “buy” rating and issued a $110.00 price target on shares of Danaher in a report on Monday, January 7th. Finally, Robert W. Baird cut their price target on shares of Danaher from $116.00 to $114.00 and set an “outperform” rating on the stock in a report on Friday, October 19th. Two analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $113.08.

COPYRIGHT VIOLATION WARNING: This report was reported by Watch List News and is the sole property of of Watch List News. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://www.watchlistnews.com/abbrea-capital-llc-acquires-120-shares-of-danaher-co-dhr/2819163.html.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

Read More: The Structure of a Futures Contract

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.